Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04163549 · ClinicalTrials.gov registry record · NA

Evaluating the Effectiveness of the Safe at Home Program

A NA study of Child Abuse and Domestic Violence, sponsored by International Rescue Committee.

Completed
Registry status
NA
Development phase
404
Enrollment target
1
Study location

NCT04163549 is a NA study of Child Abuse and Domestic Violence that has completed, run by International Rescue Committee. The registered enrollment target is 404 participants, below the 3,292-participant average among 19 other Child Abuse trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04163549, a NA study of Child Abuse and Domestic Violence, has completed, sponsored by International Rescue Committee.

COMPLETED
Registry status
NA
Development phase
404 participants
Enrollment target
1
Study location

Study Summary

The goals of the pilot RCT examining the potential effectiveness of the Safe at Home program in DRC are to: 1. Determine the potential effectiveness of Safe at Home program on improvements of family functioning and secondary outcomes of reductions in intimate partner violence and child maltreatment 2. Determine the potential effectiveness of the Safe at Home program on changes in pathway outcomes such as attitudes towards harsh discipline, gender attitudes, power-sharing, positive parenting practices, etc.

Interventions

  • BEHAVIORAL Safe at Home

Study Locations (1)

New York

  • International Rescue Committee - New York

Trial Details

FieldValue
Enrollment Target 404 participants
Start Date 2019-11-19
Est. Completion 2021-09-20
Phase NA

Sponsor

International Rescue Committee

3 total trials

What the Registry Record Tells You About NCT04163549

The ClinicalTrials.gov registry entry for NCT04163549 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 404 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,292-participant average among 19 other Child Abuse trials with a reported enrollment target (88% lower). The listed sponsor is International Rescue Committee, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Child Abuse appearing as the primary indexed condition, and to 1 intervention - of which Safe at Home is the first listed.

NCT04163549 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04163549 about?

NCT04163549 is a clinical study titled "Evaluating the Effectiveness of the Safe at Home Program". The goals of the pilot RCT examining the potential effectiveness of the Safe at Home program in DRC are to: 1. Determine the potential effectiveness of Safe at Home program on improvements of family functioning and secondary outcomes of reductions in intimate partner violence and child maltreatment...

What is the current status of trial NCT04163549?

This trial is currently completed. It is a NA study. The enrollment target is 404 participants. The study started on 2019-11-19. Estimated completion is 2021-09-20.

What conditions does trial NCT04163549 study?

This clinical trial studies the following conditions: Child Abuse, Domestic Violence, Family Functioning.

What interventions are being tested in trial NCT04163549?

The interventions under investigation include: Safe at Home (BEHAVIORAL).

Who is sponsoring clinical trial NCT04163549?

This trial is sponsored by International Rescue Committee, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04163549 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Child Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.